tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Palisade Bio (PALI)
NASDAQ:PALI
US Market
PALI
Palisade Bio
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Palisade Bio (PALI) Stock News & Sentiment

Compare
545 Followers
Palisade Bio’s Strategic Positioning and Promising Trial Results Earn Buy Rating
Premium
Ratings
Palisade Bio’s Strategic Positioning and Promising Trial Results Earn Buy Rating
12d ago
PALI
Palisade Bio’s PALI-2108: A Promising New Treatment for Ulcerative Colitis
Premium
Company Announcements
Palisade Bio’s PALI-2108: A Promising New Treatment for Ulcerative Colitis
13d ago
PALI
Palisade Bio’s Phase 1 Study on PALI-2108: A New Hope for Ulcerative Colitis Treatment
Premium
Company Announcements
Palisade Bio’s Phase 1 Study on PALI-2108: A New Hope for Ulcerative Colitis Treatment
21d ago
PALI
Palisade Bio Enters Warrant Inducement Agreement
Premium
Company Announcements
Palisade Bio Enters Warrant Inducement Agreement
26d ago
8K
PALI
Palisade Bio Appoints Emil Chuang as New Director
Premium
Company Announcements
Palisade Bio Appoints Emil Chuang as New Director
1M ago
8K
PALI
Palisade Bio Reports Improved Quarterly Losses
Premium
Company Announcements
Palisade Bio Reports Improved Quarterly Losses
3M ago
PALI
Buy Rating for Palisade Bio: Promising Phase 1a Trial Results and Strategic Focus on Unmet Needs in Crohn’s Disease
Premium
Ratings
Buy Rating for Palisade Bio: Promising Phase 1a Trial Results and Strategic Focus on Unmet Needs in Crohn’s Disease
3M ago
PALI
More PALI News >

PALI News on the Web

Palisade Bio Reports Improved Quarterly Losses
TipRanks News
Neutral
Maxim Group Sticks to Their Buy Rating for Palisade Bio (PALI)
TipRanks News
Neutral
Palisade Bio (PALI) Upgraded to Buy: What Does It Mean for the Stock?
Zacks
Bullish
Palisade Bio Participates in Virtual Investor “What This Means” Segment
Yahoo Finance
Neutral
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis
Yahoo Finance
Neutral
Palisade Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Yahoo Finance
Neutral
Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
Yahoo Finance
Neutral
Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
PALI
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PALI’s Media Buzz Sentiment?
Currently, no data Available
What is PALI’s weekly average amount of articles?
Currently, no data Available
What is PALI’s News Sentiment?
59% of articles about PALI were positive this week, compared to its sector average of 55%.
    Healthcare Stocks that are Trending in the News
    RGTLFArgent Biopharma
    TYRATyra Bioscience
    BWAYBrainsway
    OXBDFOxford BioMedica
    VKTXViking Therapeutics
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing